Genscript Biotech Corp
(STU:G51)
€
1.39
0.03 (2.21%)
Market Cap: 3.05 Bil
Enterprise Value: 1.74 Bil
PE Ratio: 0
PB Ratio: 2.62
GF Score: 72/100 Full Year 2022 Genscript Biotech Corp Earnings Presentation Transcript
Mar 30, 2023 / 11:30PM GMT
Release Date Price:
€2.07
(-2.36%)
Unidentified Company Representative
Presentation
Mar 30, 2023 / 11:30PM GMT
=====================
Corporate Participants
=====================
* Brian Hosung Min
Genscript Biotech Corporation - CEO of Biologics Business
* Shiniu Wei
Genscript Biotech Corporation - CFO
* Weihui Shao
Genscript Biotech Corporation - CEO & COO
=====================
Conference Call Participants
=====================
* Jay Lee
Morningstar Inc., Research Division - Equity Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot